サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1279917

ジェネリック医薬品の世界市場規模調査＆予測：タイプ別、用途別、製品別、投与経路別、流通チャネル別、地域別分析、2023-2030年

Global Generic Pharmaceuticals Market Size study & Forecast, by Type, by Application, by Product, By Route of Administration, by Distribution Channel and Regional Analysis, 2023-2030
出版日: | 発行: Bizwit Research & Consulting LLP | ページ情報: 英文 | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
ジェネリック医薬品の世界市場規模調査＆予測：タイプ別、用途別、製品別、投与経路別、流通チャネル別、地域別分析、2023-2030年
出版日: 2023年05月20日
発行: Bizwit Research & Consulting LLP
ページ情報: 英文
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界のジェネリック医薬品市場は、2022年に約3,617億米ドルと評価され、予測期間2022-2029年には8.3%以上の健全な成長率で成長すると予測されています。

ジェネリック医薬品は、用量、安全性、強さ、投与経路、品質、使用目的などの点で、先発医薬品と同一、または生物学的に同等な医薬品です。ジェネリック医薬品は、先発医薬品の特許が切れた後に製造されます。このため、他の製薬会社は、新薬の製造に必要な高額な研究開発に投資する必要がないため、同じ薬をより安価に製造・販売することができます。ジェネリック医薬品市場が拡大している背景には、ANDA承認の増加やジェネリック製品の上市、ジェネリック医薬品の使用を促進する政府の取り組みなどの要因が挙げられます。

ANDA承認数とジェネリック医薬品製品発売数の増加が市場成長の要因であり、米国FDAのジェネリック医薬品年次報告書によると、ANDA承認数は2020年の948件から2021年には776件に増加しました。さらに、同じソースから、2021年末までに全体で100のANDAが承認されたと報告されています。各国政府は、ジェネリック医薬品の重要なプレーヤーが医薬品への支出を削減するための様々な機会を提供するプログラムを実施しています。例として、2021年にジェネリック医薬品を使用することで、米国政府は医薬品コストを3億7,300万米ドル削減しました。AAM Generic Drug &Biosimilars Access &Savings Report 2021によると、処方箋の91%はジェネリック医薬品で満たされており、処方箋医薬品コストの18.2%を占めています。また、疾病負担の増加や老年人口の増加が、市場に有利な成長をもたらしています。しかし、ジェネリック医薬品の実際の価格に関する透明性の欠如が、市場の成長を妨げています。

ジェネリック医薬品の世界市場調査において考慮した主要地域は、アジア太平洋地域、北米、欧州、中南米、その他ラテンアメリカです。北米は、主要な市場成長の存在と、この地域の疾患有病率の増加により、収益面で市場を独占しています。これらの増加する有利な政府の取り組みと、製品の発売数の増加やジェネリック医薬品への需要が、この地域の市場成長を牽引しています。一方、アジア太平洋は、老年人口や対象人口の増加、製品開拓のための共同研究の増加、主要参入企業の地理的拡大、政府機関や非営利団体の市場参入の積極化などの要因により、予測期間中に最も高いCAGRで成長すると予想されます。

本調査の目的は、近年におけるさまざまなセグメント＆国の市場規模を定義し、今後数年間の値を予測することです。本レポートは、調査対象国の産業の質的・量的な側面を取り入れるよう設計されています。

また、市場の将来的な成長を規定する促進要因や課題など、重要な側面に関する詳細情報も提供しています。さらに、主要企業の競合情勢や製品提供の詳細な分析とともに、利害関係者が投資するためのミクロ市場での潜在的な機会も組み込んでいます。

目次

第1章 エグゼクティブサマリー

  • マーケットスナップショット
  • 世界市場・セグメント別市場の推定・予測、2020-2030年
    • ジェネリック医薬品市場：地域別、2020-2030年
    • ジェネリック医薬品市場：タイプ別、2020-2030年
    • ジェネリック医薬品市場：用途別、2020-2030年
    • ジェネリック医薬品市場：製品別、2020-2030年
    • ジェネリック医薬品市場：投与経路別、2020-2030年
    • ジェネリック医薬品市場：流通チャネル別、2020-2030年
  • 主要動向
  • 調査手法
  • 調査の前提条件

第2章 ジェネリック医薬品の世界市場の定義と範囲

  • 調査目的
  • 市場の定義とスコープ
    • 産業の進化
    • 本調査の対象範囲
  • 調査対象年
  • 通貨換算レート

第3章 ジェネリック医薬品の世界市場力学

  • ジェネリック医薬品市場のインパクト分析（2020年～2030年）
    • 市場促進要因
      • ANDA承認とジェネリック医薬品上市の増加
      • ジェネリック医薬品の利用を促進する政府の取り組み
    • 市場の課題
      • ジェネリック医薬品の高コスト
      • 価格設定の問題
    • 市場機会
      • 疾病負担の増加
      • 高齢者人口の増加

第4章 ジェネリック医薬品の世界市場産業分析

  • ポーターの5フォースモデル
    • 供給企業の交渉力
    • 買い手の交渉力
    • 新規参入業者の脅威
    • 代替品の脅威
    • 競争企業間の敵対関係
  • ポーターの5フォースインパクト分析
  • PEST分析
    • 政治的
    • 経済的
    • 社会的
    • 技術的
    • 環境
    • 法律
  • トップ投資機会
  • 主要成功戦略
  • COVID-19影響度分析
  • 破壊的動向
  • 業界専門家の視点
  • アナリストの提言と結論

第5章 ジェネリック医薬品の世界市場：タイプ別

  • 市場スナップショット
  • ジェネリック医薬品の世界市場、タイプ別実績 - ポテンシャル分析
  • ジェネリック医薬品の世界市場、タイプ別推定・予測（2020-2030年
  • ジェネリック医薬品市場、サブセグメント別分析
    • シンプル
    • 特殊
    • バイオシミラー

第6章 ジェネリック医薬品の世界市場：用途別

  • 市場スナップショット
  • ジェネリック医薬品の世界市場、用途別実績 - ポテンシャル分析
  • ジェネリック医薬品の世界市場、用途別推定・予測2020-2030
  • ジェネリック医薬品市場、サブセグメント別分析
    • 中枢神経系疾患
    • 呼吸器系疾患
    • ホルモン・関連疾患
    • 消化器系疾患
    • 循環器系疾患
    • 感染症
    • その他

第7章 ジェネリック医薬品の世界市場：製品別

  • 市場スナップショット
  • ジェネリック医薬品の世界市場、製品別実績 - ポテンシャル分析
  • ジェネリック医薬品の世界市場、製品別推定・予測2020-2030
  • ジェネリック医薬品市場、サブセグメント別分析
    • 低分子
    • 高分子

第8章 ジェネリック医薬品の世界市場：投与経路別

  • 市場スナップショット
  • ジェネリック医薬品の世界市場：投与経路別、業績-ポテンシャル分析
  • ジェネリック医薬品の世界市場、投与経路別推定・予測（2020-2030年
  • ジェネリック医薬品市場、サブセグメント別分析
    • 経口剤
    • 注射剤
    • 吸入剤
    • その他

第9章 ジェネリック医薬品の世界市場：流通チャネル別

  • 市場スナップショット
  • ジェネリック医薬品の世界市場：流通チャネル別実績-ポテンシャル分析
  • ジェネリック医薬品の世界市場、流通チャネル別推定・予測2020-2030
  • ジェネリック医薬品市場、サブセグメント別分析
    • オンライン薬局
    • 小売薬局
    • 病院薬局

第10章 ジェネリック医薬品の世界市場：地域別分析

  • 上位の主要国
  • 上位新興国
  • ジェネリック医薬品市場、地域別市場スナップショット
  • 北米
    • 米国
      • タイプ別推定・予測、2020-2030年
      • 用途別の推定・予測、2020-2030年
      • 製品別の推定・予測、2020-2030年
      • 投与経路別の推定・予測、2020-2030年
      • 流通チャネル別の推定・予測、2020-2030年
    • カナダ
  • 欧州ジェネリック医薬品市場スナップショット
    • 英国
    • ドイツ
    • フランス
    • スペイン
    • イタリア
    • その他欧州
  • アジア太平洋地域のジェネリック医薬品市場スナップショット
    • 中国
    • インド
    • 日本
    • オーストラリア
    • 韓国
    • その他アジア太平洋地域
  • ラテンアメリカのジェネリック医薬品市場スナップショット
    • ブラジル
    • メキシコ
  • 世界のその他の地域

第11章 競合情報

  • 主要企業のSWOT分析
  • トップ市場戦略
  • 企業プロファイル
    • Teva Pharmaceutical Industries Ltd.
      • 主要情報
      • 概要
      • 財務情報（データの入手が可能な場合のみ）
      • 製品概要
      • 最近の開発状況
    • Viatris Inc.
    • Novartis AG
    • Sun Pharmaceutical Industries Ltd.
    • LUPIN
    • AbbVie Inc.（Allergan）
    • AstraZeneca
    • Sawai Pharmaceutical Co., Ltd.
    • Hikma Pharmaceuticals PLC
    • Dr. Reddy's Laboratories Ltd.

第12章 調査プロセス

  • 調査プロセス
    • データマイニング
    • 分析
    • 市場推定
    • バリデーション
    • 出版
  • 調査の特徴
  • 調査の前提条件
図表

LIST OF TABLES

  • TABLE 1. Global Generic Pharmaceuticals Market, report scope
  • TABLE 2. Global Generic Pharmaceuticals Market estimates & forecasts by Region 2020-2030 (USD Billion)
  • TABLE 3. Global Generic Pharmaceuticals Market estimates & forecasts by Type 2020-2030 (USD Billion)
  • TABLE 4. Global Generic Pharmaceuticals Market estimates & forecasts by Application 2020-2030 (USD Billion)
  • TABLE 5. Global Generic Pharmaceuticals Market estimates & forecasts by Product 2020-2030 (USD Billion)
  • TABLE 6. Global Generic Pharmaceuticals Market estimates & forecasts by Route of Administration 2020-2030 (USD Billion)
  • TABLE 7. Global Generic Pharmaceuticals Market estimates & forecasts by Distribution Channel 2020-2030 (USD Billion)
  • TABLE 8. Global Generic Pharmaceuticals Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 9. Global Generic Pharmaceuticals Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 10. Global Generic Pharmaceuticals Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 11. Global Generic Pharmaceuticals Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 12. Global Generic Pharmaceuticals Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 13. Global Generic Pharmaceuticals Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 14. Global Generic Pharmaceuticals Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 15. Global Generic Pharmaceuticals Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 16. Global Generic Pharmaceuticals Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 17. Global Generic Pharmaceuticals Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 18. U.S. Generic Pharmaceuticals Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 19. U.S. Generic Pharmaceuticals Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 20. U.S. Generic Pharmaceuticals Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 21. Canada Generic Pharmaceuticals Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 22. Canada Generic Pharmaceuticals Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 23. Canada Generic Pharmaceuticals Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 24. UK Generic Pharmaceuticals Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 25. UK Generic Pharmaceuticals Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 26. UK Generic Pharmaceuticals Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 27. Germany Generic Pharmaceuticals Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 28. Germany Generic Pharmaceuticals Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 29. Germany Generic Pharmaceuticals Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 30. France Generic Pharmaceuticals Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 31. France Generic Pharmaceuticals Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 32. France Generic Pharmaceuticals Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 33. Italy Generic Pharmaceuticals Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 34. Italy Generic Pharmaceuticals Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 35. Italy Generic Pharmaceuticals Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 36. Spain Generic Pharmaceuticals Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 37. Spain Generic Pharmaceuticals Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 38. Spain Generic Pharmaceuticals Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 39. RoE Generic Pharmaceuticals Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 40. RoE Generic Pharmaceuticals Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 41. RoE Generic Pharmaceuticals Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 42. China Generic Pharmaceuticals Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 43. China Generic Pharmaceuticals Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 44. China Generic Pharmaceuticals Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 45. India Generic Pharmaceuticals Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 46. India Generic Pharmaceuticals Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 47. India Generic Pharmaceuticals Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 48. Japan Generic Pharmaceuticals Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 49. Japan Generic Pharmaceuticals Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 50. Japan Generic Pharmaceuticals Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 51. South Korea Generic Pharmaceuticals Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 52. South Korea Generic Pharmaceuticals Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 53. South Korea Generic Pharmaceuticals Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 54. Australia Generic Pharmaceuticals Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 55. Australia Generic Pharmaceuticals Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 56. Australia Generic Pharmaceuticals Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 57. RoAPAC Generic Pharmaceuticals Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 58. RoAPAC Generic Pharmaceuticals Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 59. RoAPAC Generic Pharmaceuticals Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 60. Brazil Generic Pharmaceuticals Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 61. Brazil Generic Pharmaceuticals Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 62. Brazil Generic Pharmaceuticals Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 63. Mexico Generic Pharmaceuticals Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 64. Mexico Generic Pharmaceuticals Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 65. Mexico Generic Pharmaceuticals Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 66. RoLA Generic Pharmaceuticals Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 67. RoLA Generic Pharmaceuticals Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 68. RoLA Generic Pharmaceuticals Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 69. Saudi Arabia Generic Pharmaceuticals Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 70. South Africa Generic Pharmaceuticals Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 71. RoMEA Generic Pharmaceuticals Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 72. List of secondary sources, used in the study of global Generic Pharmaceuticals Market
  • TABLE 73. List of primary sources, used in the study of global Generic Pharmaceuticals Market
  • TABLE 74. Years considered for the study
  • TABLE 75. Exchange rates considered

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

LIST OF FIGURES

List of figures

  • FIG 1. Global Generic Pharmaceuticals Market, research methodology
  • FIG 2. Global Generic Pharmaceuticals Market, Market estimation techniques
  • FIG 3. Global Market size estimates & forecast methods
  • FIG 4. Global Generic Pharmaceuticals Market, key trends 2022
  • FIG 5. Global Generic Pharmaceuticals Market, growth prospects 2023-2030
  • FIG 6. Global Generic Pharmaceuticals Market, porters 5 force model
  • FIG 7. Global Generic Pharmaceuticals Market, pest analysis
  • FIG 8. Global Generic Pharmaceuticals Market, value chain analysis
  • FIG 9. Global Generic Pharmaceuticals Market by segment, 2020 & 2030 (USD Billion)
  • FIG 10. Global Generic Pharmaceuticals Market by segment, 2020 & 2030 (USD Billion)
  • FIG 11. Global Generic Pharmaceuticals Market by segment, 2020 & 2030 (USD Billion)
  • FIG 12. Global Generic Pharmaceuticals Market by segment, 2020 & 2030 (USD Billion)
  • FIG 13. Global Generic Pharmaceuticals Market by segment, 2020 & 2030 (USD Billion)
  • FIG 14. Global Generic Pharmaceuticals Market, regional snapshot 2020 & 2030
  • FIG 15. North America Generic Pharmaceuticals Market 2020 & 2030 (USD Billion)
  • FIG 16. Europe Generic Pharmaceuticals Market 2020 & 2030 (USD Billion)
  • FIG 17. Asia pacific Generic Pharmaceuticals Market 2020 & 2030 (USD Billion)
  • FIG 18. Latin America Generic Pharmaceuticals Market 2020 & 2030 (USD Billion)
  • FIG 19. Middle East & Africa Generic Pharmaceuticals Market 2020 & 2030 (USD Billion)

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

目次

Global Generic Pharmaceuticals Market is valued at approximately USD 361.7 billion in 2022 and is anticipated to grow with a healthy growth rate of more than 8.3% over the forecast period 2022-2029. Generic pharmaceuticals are medications that are identical, or bioequivalent, to brand-name drugs in terms of dosage, safety, strength, route of administration, quality, and intended use. Generic drugs are produced after the patent for the original brand-name drug has expired. This allows other pharmaceutical companies to manufacture and sell the same medication at a lower cost because they do not need to invest in the costly research and development that is required to create a new drug. The Generic Pharmaceuticals market is expanding because of factors such as rising, increasing ANDA approval and generic product launches and government initiatives to promote the usage of generics.

The rise in the number of ANDA approvals and generic medication product launches accounts for the market growth. according to the U.S. FDA's Generic Drugs Annual report, the number of ANDA approvals increased from 948 in 2020 to 776 in 2021. Additionally, from the same source, it was reported that 100 ANDAs had been approved overall by the end of 2021. Governments have implemented programs that offer various opportunities for significant generic drug players to cut back on expenditure on pharmaceuticals. As an illustration, by using generic medications in 2021, the U.S. government saved USD 373 million on pharmaceutical costs. According to the AAM Generic Drug & Biosimilars Access & Savings Report 2021, 91% of prescriptions are filled with generic medication, which represents 18.2% of prescription drug costs. In addition, the increasing Disease Burden and Rising Geriatric Population are creating lucrative growth in the market. However, a lack of transparency about the actual price of generic drugs hampers the market growth.

The key regions considered for the Global Generic Pharmaceuticals Market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America dominated the market in terms of revenue, owing to the presence of key market growth and the region's increasing disease prevalence, along with these increasing number of favorable government initiatives coupled with the rising number of product launches and demand for a generic drug is driving the market growth in the region. Whereas Asia Pacific is expected to grow with the highest CAGR during the forecast period, owing to factors such as rising geriatric and target populations, an increase in the number of collaborations for product development, geographic expansion of key players, and active participation of government and nonprofit organizations in the market space.

Major market players included in this report are:

  • Teva Pharmaceutical Industries Ltd.
  • Viatris Inc.
  • Novartis AG
  • Sun Pharmaceutical Industries Ltd.
  • LUPIN
  • AbbVie Inc. (Allergan)
  • AstraZeneca
  • Sawai Pharmaceutical Co., Ltd.
  • Hikma Pharmaceuticals PLC
  • Dr. Reddy's Laboratories Ltd.

Recent Developments in the Market:

  • In January 2022, the Mark Cuban Cost Plus Drugs Company (MCCPDC) announced the launch of an online pharmacy. The pharmacy would offer around more than 100 generic drugs at a low cost to patients.

Global Generic Pharmaceuticals Market Report Scope:

  • Historical Data: - 2020 - 2021
  • Base Year for Estimation: - 2022
  • Forecast period: - 2023-2030
  • Report Coverage: - Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
  • Segments Covered: - Type, Application, Product, Application, Route of Administration, Distribution Channel, Region
  • Regional Scope: - North America; Europe; Asia Pacific; Latin America; Middle East & Africa
  • Customization Scope: - Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below.

By Type:

  • Simple Generics
  • Specialty Generics
  • Biosimilars

By Application:

  • Central Nervous System Disorders
  • Respiratory Diseases
  • Hormones & Related Diseases
  • Gastrointestinal Diseases
  • Cardiovascular Diseases
  • Infectious Diseases
  • Others

By Product:

  • Small Molecule
  • Large Molecule

By Route of Administration:

  • Oral
  • Injectable
  • Inhalable
  • Others

Distribution Channel:

  • Online Pharmacies
  • Hospitals Pharmacies
  • Retail Pharmacies

By Region:

  • North America
  • U.S.
  • Canada
  • Europe
  • UK
  • Germany
  • France
  • Spain
  • Italy
  • ROE
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • RoAPAC
  • Latin America
  • Brazil
  • Mexico
  • RoLA
  • Middle East & Africa
  • Saudi Arabia
  • South Africa
  • Rest of Middle East & Africa

Table of Contents

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Billion)
    • 1.2.1. Generic Pharmaceuticals Market, by Region, 2020-2030 (USD Billion)
    • 1.2.2. Generic Pharmaceuticals Market, by Type, 2020-2030 (USD Billion)
    • 1.2.3. Generic Pharmaceuticals Market, by Application, 2020-2030 (USD Billion)
    • 1.2.4. Generic Pharmaceuticals Market, by Product, 2020-2030 (USD Billion)
    • 1.2.5. Generic Pharmaceuticals Market, by Route of Administration, 2020-2030 (USD Billion)
    • 1.2.6. Generic Pharmaceuticals Market, by Distribution Channel, 2020-2030 (USD Billion)
  • 1.3. Key Trends
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global Generic Pharmaceuticals Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Industry Evolution
    • 2.2.2. Scope of the Study
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global Generic Pharmaceuticals Market Dynamics

  • 3.1. Generic Pharmaceuticals Market Impact Analysis (2020-2030)
    • 3.1.1. Market Drivers
      • 3.1.1.1. Increasing ANDA approval and Generic Product Launches
      • 3.1.1.2. Government initiatives to promote usage of generics
    • 3.1.2. Market Challenges
      • 3.1.2.1. High Cost of Generic Pharmaceuticals
      • 3.1.2.2. Pricing issues
    • 3.1.3. Market Opportunities
      • 3.1.3.1. Increasing Disease Burden
      • 3.1.3.2. Rising Geriatric Population

Chapter 4. Global Generic Pharmaceuticals Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
  • 4.2. Porter's 5 Force Impact Analysis
  • 4.3. PEST Analysis
    • 4.3.1. Political
    • 4.3.2. Economical
    • 4.3.3. Social
    • 4.3.4. Technological
    • 4.3.5. Environmental
    • 4.3.6. Legal
  • 4.4. Top investment opportunity
  • 4.5. Top winning strategies
  • 4.6. COVID-19 Impact Analysis
  • 4.7. Disruptive Trends
  • 4.8. Industry Expert Perspective
  • 4.9. Analyst Recommendation & Conclusion

Chapter 5. Global Generic Pharmaceuticals Market, by Type

  • 5.1. Market Snapshot
  • 5.2. Global Generic Pharmaceuticals Market by Type, Performance - Potential Analysis
  • 5.3. Global Generic Pharmaceuticals Market Estimates & Forecasts by Type 2020-2030 (USD Billion)
  • 5.4. Generic Pharmaceuticals Market, Sub Segment Analysis
    • 5.4.1. Simple Generics
    • 5.4.2. Specialty Generics
    • 5.4.3. Biosimilars

Chapter 6. Global Generic Pharmaceuticals Market, by Application

  • 6.1. Market Snapshot
  • 6.2. Global Generic Pharmaceuticals Market by Application, Performance - Potential Analysis
  • 6.3. Global Generic Pharmaceuticals Market Estimates & Forecasts by Application 2020-2030 (USD Billion)
  • 6.4. Generic Pharmaceuticals Market, Sub Segment Analysis
    • 6.4.1. Central Nervous System Disorders
    • 6.4.2. Respiratory Diseases
    • 6.4.3. Hormones & Related Diseases
    • 6.4.4. Gastrointestinal Diseases
    • 6.4.5. Cardiovascular Diseases
    • 6.4.6. Infectious Diseases
    • 6.4.7. Others

Chapter 7. Global Generic Pharmaceuticals Market, by Product

  • 7.1. Market Snapshot
  • 7.2. Global Generic Pharmaceuticals Market by Product, Performance - Potential Analysis
  • 7.3. Global Generic Pharmaceuticals Market Estimates & Forecasts by Product 2020-2030 (USD Billion)
  • 7.4. Generic Pharmaceuticals Market, Sub Segment Analysis
    • 7.4.1. Small Molecule
    • 7.4.2. Large Molecule

Chapter 8. Global Generic Pharmaceuticals Market, by Route of Administration

  • 8.1. Market Snapshot
  • 8.2. Global Generic Pharmaceuticals Market by Route of Administration, Performance - Potential Analysis
  • 8.3. Global Generic Pharmaceuticals Market Estimates & Forecasts by Route of Administration 2020-2030 (USD Billion)
  • 8.4. Generic Pharmaceuticals Market, Sub Segment Analysis
    • 8.4.1. Oral
    • 8.4.2. Injectable
    • 8.4.3. Inhalable
    • 8.4.4. Others

Chapter 9. Global Generic Pharmaceuticals Market, by Distribution Channel

  • 9.1. Market Snapshot
  • 9.2. Global Generic Pharmaceuticals Market by Distribution Channel, Performance - Potential Analysis
  • 9.3. Global Generic Pharmaceuticals Market Estimates & Forecasts by Distribution channel 2020-2030 (USD Billion)
  • 9.4. Generic Pharmaceuticals Market, Sub Segment Analysis
    • 9.4.1. Online Pharmacies
    • 9.4.2. Retail Pharmacies
    • 9.4.3. Hospital Pharmacies

Chapter 10. Global Generic Pharmaceuticals Market, Regional Analysis

  • 10.1. Top Leading Countries
  • 10.2. Top Emerging Countries
  • 10.3. Generic Pharmaceuticals Market, Regional Market Snapshot
  • 10.4. North America Generic Pharmaceuticals Market
    • 10.4.1. U.S. Generic Pharmaceuticals Market
      • 10.4.1.1. Type breakdown estimates & forecasts, 2020-2030
      • 10.4.1.2. Application breakdown estimates & forecasts, 2020-2030
      • 10.4.1.3. Product breakdown estimates & forecasts, 2020-2030
      • 10.4.1.4. Route of Administration breakdown estimates & forecasts, 2020-2030 10.4.1.5. Distribution Channel breakdown estimates & forecasts, 2020-2030
    • 10.4.2. Canada Generic Pharmaceuticals Market
  • 10.5. Europe Generic Pharmaceuticals Market Snapshot
    • 10.5.1. U.K. Generic Pharmaceuticals Market
    • 10.5.2. Germany Generic Pharmaceuticals Market
    • 10.5.3. France Generic Pharmaceuticals Market
    • 10.5.4. Spain Generic Pharmaceuticals Market
    • 10.5.5. Italy Generic Pharmaceuticals Market
    • 10.5.6. Rest of Europe Generic Pharmaceuticals Market
  • 10.6. Asia-Pacific Generic Pharmaceuticals Market Snapshot
    • 10.6.1. China Generic Pharmaceuticals Market
    • 10.6.2. India Generic Pharmaceuticals Market
    • 10.6.3. Japan Generic Pharmaceuticals Market
    • 10.6.4. Australia Generic Pharmaceuticals Market
    • 10.6.5. South Korea Generic Pharmaceuticals Market
    • 10.6.6. Rest of Asia Pacific Generic Pharmaceuticals Market
  • 10.7. Latin America Generic Pharmaceuticals Market Snapshot
    • 10.7.1. Brazil Generic Pharmaceuticals Market
    • 10.7.2. Mexico Generic Pharmaceuticals Market
  • 10.8. Rest of The World Generic Pharmaceuticals Market

Chapter 11. Competitive Intelligence

  • 11.1. Key Company SWOT Analysis
    • 11.1.1. Company 1
    • 11.1.2. Company 2
    • 11.1.3. Company 3
  • 11.2. Top Market Strategies
  • 11.3. Company Profiles
    • 11.3.1. Teva Pharmaceutical Industries Ltd.
      • 11.3.1.1. Key Information
      • 11.3.1.2. Overview
      • 11.3.1.3. Financial (Subject to Data Availability)
      • 11.3.1.4. Product Summary
      • 11.3.1.5. Recent Developments
    • 11.3.2. Viatris Inc.
    • 11.3.3. Novartis AG
    • 11.3.4. Sun Pharmaceutical Industries Ltd.
    • 11.3.5. LUPIN
    • 11.3.6. AbbVie Inc. (Allergan)
    • 11.3.7. AstraZeneca
    • 11.3.8. Sawai Pharmaceutical Co., Ltd.
    • 11.3.9. Hikma Pharmaceuticals PLC
    • 11.3.10. Dr. Reddy's Laboratories Ltd.

Chapter 12. Research Process

  • 12.1. Research Process
    • 12.1.1. Data Mining
    • 12.1.2. Analysis
    • 12.1.3. Market Estimation
    • 12.1.4. Validation
    • 12.1.5. Publishing
  • 12.2. Research Attributes
  • 12.3. Research Assumption